LNSR logo

LENSAR INC

LNSRNASDAQ
🏆 #4176 by market capUS Equity
$6.95▲ $0.13 (+1.91%)
Pre-market · at close
🔔
Track LNSR
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 1.9%
7d▼ 2.0%
14d▼ 2.3%
30d▼ 17.9%
ytd▼ 40.1%
1y▼ 43.4%
🏦Market Cap
$85M
Small Cap
📈Revenue Growth (YoY)
+3.3%
Slowing
📊Gross Margin
46.4%
Healthy
💵FCF Margin
—
⚖️P/S Ratio
1.4x
Cheap
Otter Score
80
Good

Trading Snapshot

Day Range
$6.87 – $7.08
52-Week Range
$4.95 – $12.94
Volume
$4.78B
Avg Volume
$6.23B
Shares Outstanding
12.3M
Next Earnings
Nov 23, 2026

Fundamentals Snapshot

Annual Revenue
$58M
Last Q Revenue
$16M
P/E Ratio
2.4
P/S Ratio
1.4x
EPS (TTM)
$2.08
Dividend Yield
—
Dilution (1yr)
+3.8%

Why Investors Own LNSR

  • ✓High-growth profile — revenue up +52.9% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 77% gross margin and 16% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

LNSR logo

LENSAR INC

LNSR
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$58M▲ +9.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
46.4%▼ −4.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$25M▲ +130.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$15M▲ +513.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
12.1M▲ +3.8% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$10M▼ −$3M YoY
StockOtter · stockotter.space

About LENSAR INC

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Good
80/100

Analyst Price Target

ⓘ
Average Target
$8.74
▲ +25.8% Upside
High Target$10.94
Low Target$7.02
Based on 33 analysts

Latest News & Updates

🚀
CNBC·2h ago

LENSAR INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
Barron’s·5h ago

Analysts lift LNSR price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
MarketWatch·1d ago

LENSAR INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.